| Trial ID: | L4711 |
| Source ID: | NCT03631121
|
| Associated Drug: |
Basalin To Lantus
|
| Title: |
Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes
|
| Interventions: |
DRUG: Basalin to Lantus
|
| Outcome Measures: |
Primary: Change of glycemic variation, The changes of glycemic variation before and after drug change, Day 1-13 |
|
| Sponsor/Collaborators: |
Sponsor: Nanjing First Hospital, Nanjing Medical University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-08-15
|
| Completion Date: |
2019-07-30
|
| Results First Posted: |
|
| Last Update Posted: |
2019-06-11
|
| Locations: |
Nanjing First Hostital, Nanjing, Jiangsu, 210000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03631121
|
